Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Vesper JL and Fenske NA Hair darkening and new growth associated with etretinate therapy. 1996 J. Am. Acad. Dermatol. pmid:8632091
Almond-Roesler B and Orfanos CE [Trans-acitretin is metabolized back to etretinate. Importance for oral retinoid therapy]. 1996 Hautarzt pmid:8647698
Panzarella K and Camisa C Coexistence of superficial pemphigus and psoriasis. 1996 Cutis pmid:8804843
Lacour M et al. An appraisal of acitretin therapy in children with inherited disorders of keratinization. 1996 Br. J. Dermatol. pmid:8763418
Van Dooren-Greebe RJ et al. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities. 1996 Br. J. Dermatol. pmid:8745889
Bolla M et al. Prevention of second primary tumours with a second generation retinoid in squamous cell carcinoma of oral cavity and oropharynx: long term follow-up. 1996 Eur. J. Cancer pmid:8664063
Whitmore SE Osteoporosis and long-term etretinate therapy. 1996 Arch Dermatol pmid:8651729
Margolis DJ Osteoporosis and long-term etretinate therapy. 1996 Arch Dermatol pmid:8651730
Finkelstein E et al. Treatment of xeroderma pigmentosum variant with low-dose etretinate. 1996 Br. J. Dermatol. pmid:8733405
Gruber F et al. Treatment of lipoid proteinosis with etretinate. 1996 Acta Derm. Venereol. pmid:8740275
Hudson-Peacock MJ et al. Response of PUVA-induced keratoses to etretinate. 1996 J. Am. Acad. Dermatol. pmid:8682951
Adam AE Ectopic Darier's disease of the cervix: an extraordinary cause of an abnormal smear. 1996 Cytopathology pmid:8958475
Hunt MJ et al. Vesiculobullous Hailey-Hailey disease: successful treatment with oral retinoids. 1996 Australas. J. Dermatol. pmid:8961587
Stosić-Grujicić S et al. Etretinate (Ro 10-9359) prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats. 1996 Transplant. Proc. pmid:8962263
Schepers C et al. Papuloerythroderma of Ofuji: a report of 2 cases including the first European case associated with visceral carcinoma. 1996 Dermatology (Basel) pmid:8884150
Maier H and Hönigsmann H Concentration of etretinate in plasma and subcutaneous fat after long-term acitretin. 1996 Lancet pmid:8874484
Haftek M et al. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. 1996 Br. J. Dermatol. pmid:8949442
Danno K et al. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. 1996 J. Dermatol. Sci. pmid:8902653
Lundgren T et al. Systemic retinoid medication and periodontal health in patients with Papillon-Lefèvre syndrome. 1996 J. Clin. Periodontol. pmid:8707975
Pomponi F et al. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 1996 Blood pmid:8874215
Lo Schiavo A et al. [Keratoacanthoma centrifugum marginatum. Possible etiological role of papillomavirus and therapeutic response to etretinate]. 1996 Ann Dermatol Venereol pmid:9615129
Kremer I et al. The effect of topical retinoic acid (Etretinate) on mouse conjunctival Langerhans cells. 1995 Curr. Eye Res. pmid:7796600
Theiler R et al. High-turnover osteoporosis and diffuse idiopathic skeletal hyperostosis induced by retinoid therapy in a patient with superficial bladder cancer. 1995 Br J Urol pmid:7551859
Arthur EA et al. Palmoplantar keratoderma associated with dermatopathia pigmentosa reticularis: successful treatment with etretinate. 1995 Int. J. Dermatol. pmid:7591467
Stern RS et al. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. 1995 J. Am. Acad. Dermatol. pmid:7601945
Lim HW and Harris HR Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T cell lymphoma undergoing photopheresis. 1995 Dermatol Surg pmid:7606369
Mahrle G et al. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. 1995 J. Am. Acad. Dermatol. pmid:7822521
Puig L and de Moragas JM Confluent and reticulated papillomatosis of Gougerot and Carteaud: minocycline deserves trial before etretinate. 1995 Arch Dermatol pmid:7826088
Dev V et al. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: comparative study of two drugs. 1995 Cathet Cardiovasc Diagn pmid:7497499
DiGiovanna JJ et al. Osteoporosis is a toxic effect of long-term etretinate therapy. 1995 Arch Dermatol pmid:7503569
Wyss M et al. Lymphomatoid papulosis--treatment with recombinant interferon alfa-2a and etretinate. 1995 Dermatology (Basel) pmid:7655107
Decker MA and Zimmerman CL Simultaneous determination of etretinate, acitretin and their metabolites in perfusate, perfusate plasma, bile or hepatic tissue with reversed-phase high-performance liquid chromatography. 1995 J. Chromatogr. B, Biomed. Appl. pmid:7663673
Berth-Jones J and Hutchinson PE Novel cycle changes in scalp hair are caused by etretinate therapy. 1995 Br. J. Dermatol. pmid:7718452
Boateng B et al. [Multiple keratoacanthomas (Witten-Zak type) in prurigo simplex subacuta]. 1995 Hautarzt pmid:7706068
Goldman GD and Milstone LM Generalized linear porokeratosis treated with etretinate. 1995 Arch Dermatol pmid:7726603
Studer UE et al. Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland. 1995 Eur. Urol. pmid:8575494
Zhang JZ et al. Production and secretion of platelet-derived growth factor AB by cultured human keratinocytes: regulatory effects of phorbol 12-myristate 13-acetate, etretinate, 1,25-dihydroxyvitamin D3, and several cytokines. 1995 J. Dermatol. pmid:7673548
Hayashi M et al. Male fertility in rats treated with etretinate for 4 weeks. 1995 J Toxicol Sci pmid:8667453
Kudo T [Retinoic acid-induced hyperostosis in the murine spine, particularly in the cervical spine]. 1995 Nippon Seikeigeka Gakkai Zasshi pmid:8530889
Delaporte E et al. Keratoderma with scleroatrophy of the extremities or sclerotylosis (Huriez syndrome): a reappraisal. 1995 Br. J. Dermatol. pmid:8546996
Fabrizi G et al. [Linear porokeratosis]. 1995 Ann Dermatol Venereol pmid:8526433
van Dooren-Greebe RJ and van de Kerkhof PC Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. 1995 J. Am. Acad. Dermatol. pmid:7829733
Rook AH et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. 1995 Transplantation pmid:7886798
Martini P et al. Darier-White syndrome and cyclosporin. 1995 Dermatology (Basel) pmid:7727845
Elchalal U et al. Treatment of vulvar lichen sclerosus in the elderly: an update. 1995 Obstet Gynecol Surv pmid:7731628
Schmitt-Hoffmann AH et al. Mechanistic studies on the ethyl-esterification of acitretin by human liver preparations in vitro. 1995 Life Sci. pmid:8847958
Bhattacharya J et al. Case of the month: " ... or plat du jour". 1995 Br J Radiol pmid:7788246
Peris K et al. Keratoderma hereditarium mutilans (Vohwinkel's syndrome) associated with congenital deaf-mutism. 1995 Br. J. Dermatol. pmid:7748756
Elbaum DJ et al. Increased incidence of cutaneous carcinomas in patients with congenital ichthyosis. 1995 J. Am. Acad. Dermatol. pmid:7593802
Shigematsu T and Tajima S Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts. 1995 J. Dermatol. Sci. pmid:7772577